Pharmacy Medical News about Insulin

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Engineering study comparing injection force and dose accuracy between two prefilled insulin injection pens
Current Medical Research and Opinion, 10/08/09

Ignaut DA et al. – The insulin lispro pen had significantly lower median GF and GFV compared with insulin aspart pen when tested at two dose sizes and two dosing speeds. Median dose error was similar between the device types at the 10U/s dosing speed, but median dose error was significantly lower for the insulin lispro pen at the 6.6U/s dosing speed. A limitation of this study was that it was executed as an open label study.

<< Previous
The Effect of Pharmaceutical Care Programs on Blood Pressure...

Next >>
Sitagliptin 100mg daily effect on DPP-4 inhibition and...

Evolution, body composition, insulin receptor competition, and insulin resistance
Preventive Medicine, 11/02/09 Relevance Score: 97%

Comparison of Prandial AIR Inhaled Insulin Alone to Intensified Insulin Glargine Alone and to AIR Insulin Plus Intensified Insulin Glargine in Patients with Type 2 Diabetes Previously Treated with Once-Daily Insulin Glargine
Diabetes Technology & Therapeutics, 10/05/09 Relevance Score: 96%

U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09 Relevance Score: 95%

Central Insulin Signaling Is Attenuated by Long-Term Insulin Exposure via Insulin Receptor Substrate-1 Serine Phosphorylation, Proteasomal Degradation, and Lysosomal Insulin Receptor Degradation
Endocrinology, 11/06/09 Relevance Score: 94%

Initiation of Prandial Insulin Therapy with AIR Inhaled Insulin or Insulin Lispro in Patients with Type 2 Diabetes: A Randomized Noninferiority Trial
Diabetes Technology & Therapeutics, 10/02/09 Relevance Score: 94%